Christopher R. Seaton

Chairman at Middlesex Hospital

Health Services

Consumer Services

Health Technology

Profile

Christopher R.
Seaton is currently the Chairman at Middlesex Hospital and Director at Versantis AG.
He completed his undergraduate and MBA degrees from McMaster University.

Christopher R. Seaton active positions

Companies	Position	Start
Middlesex Hospital Middlesex Hospital Hospital/Nursing ManagementHealth Services Middlesex Hospital, located in Middletown, CT, provides healthcare services to patients and families. The hospital prides itself on providing quality care and treating patients like family.	Chairman	2010-04-18
Versantis AG Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland.	Director/Board Member	2021-02-04

All active positions of Christopher R. Seaton

Training of Christopher R. Seaton

McMaster University

Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christopher R. Seaton's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Middlesex Hospital Middlesex Hospital Hospital/Nursing ManagementHealth Services Middlesex Hospital, located in Middletown, CT, provides healthcare services to patients and families. The hospital prides itself on providing quality care and treating patients like family.	Health Services
Versantis AG Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland.	Health Technology